title: [Off-label use in oncology. The Italian choice].
abstract: In a context in which there is doubt as to the efficacy and safety of cancer drugs recently put on the market, the off-label use of these drugs complicates the situation. The Italian government, unlike some others, has opted to lay down strict rules regarding off-label use, in order to ensure greater efficacy and safety for patients.
authors.forename: Viviana
authors.initials: V
authors.lastname: Felicetti
authors.forename: Ugo
authors.initials: U
authors.lastname: Gremigni
authors.forename: Luciano
authors.initials: L
authors.lastname: Cifaldi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D007558:Italy; D008495:Medical Oncology / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational